Holen Sie sich die Stockscreener-App
88.95
0.33%
0.29
Handel nachbörslich:
88.95
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific Corp. stock rises Friday, still underperforms market - MarketWatch
Truist maintains Buy on Boston Scientific with $110 target - Investing.com
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries - Benzinga
Should You Be Adding Boston Scientific (NYSE:BSX) To Your Watchlist Today? - Yahoo Finance
Principal Financial Group Inc. Buys 111,724 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pain Management Devices Market May See a Big Move | Medtronic, Boston Scientific, LivaNova - openPR
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy - Yahoo Finance
Boston Scientific updates instructions for cryoablation catheters after reported deaths - Mass Device
Boston Scientific price target raised to $110 from $100 at Truist - Yahoo Finance
Boston Scientific updates cryoablation catheter instructions after 4 death reports - Yahoo Finance
FDA classifies recall of Boston Scientific catheters as 'most serious' - Reuters.com
FDA classifies recall of Boston Scientific catheters as 'most serious' By Reuters - Investing.com
Boston Scientific shares target increased, holds Buy on growth prospects - Investing.com
Boston Scientific (NYSE:BSX) Price Target Raised to $110.00 - MarketBeat
Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific recalls Accolade pacemakers tied to 2 deaths - Yahoo Finance
Boston Scientific warns on potential need to replace Accolade pacemaker devices early - Mass Device
Boston Scientific has a new Peripheral Interventions leader in EMEA - Mass Device
Sanctuary Advisors LLC Sells 6,069 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Wilmington Savings Fund Society FSB Makes New Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 121% gain - Yahoo Finance
Short Interest in Boston Scientific Co. (NYSE:BSX) Grows By 11.2% - MarketBeat
Jim Cramer on Boston Scientific Corporation (BSX): ‘A Superior Company’ - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Zacks Investment Research
Oddo BHF Asset Management Sas Buys New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Franklin Resources Inc. - MarketBeat
Boston Scientific best idea at TD Cowen, lifts PT by $10 - Investing.com
Boston Scientific shares target lifted, buy rating on robust performance - Investing.com
Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes - Yahoo Finance
Boston Scientific Co. (NYSE:BSX) Shares Sold by Toronto Dominion Bank - MarketBeat
Teachers Retirement System of The State of Kentucky Sells 150,603 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
TCW Group Inc. Sells 147,999 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace - Quantisnow
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace – Company Announcement - Financial Times
Brown Financial Advisors Has $1.04 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Vestcor Inc Has $3.38 Million Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific Corporation (NYSE:BSX) Could Be Worth Watching - Yahoo Finance
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) Stock Holdings Decreased by Nomura Asset Management Co. Ltd. - MarketBeat
Boston Scientific Co. (NYSE:BSX) Position Increased by Zacks Investment Management - MarketBeat
National Bank of Canada FI Increases Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
United Services Automobile Association Sells 7,295 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Worldquant Millennium Advisors LLC Makes New $9.04 Million Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Canada Finance
Layoffs in medtech: These companies recently reduced their workforce - Mass Device
Soros Fund Management LLC Buys 100,000 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stock Position Increased by Stifel Financial Corp - MarketBeat
Disposable Endoscope Market Report 2024 - GlobeNewswire Inc.
Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Boston Scientific (STU:BSX) EV-to-Revenue : 9.31 (As of Dec. 05, 2024) - GuruFocus.com
Redmile Group LLC Lowers Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Miura Global Management LLC Reduces Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Hilltop Holdings Inc. Purchases 7,564 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Captrust Financial Advisors Trims Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):